Abaloparatide CAS:247062-33-5

Abaloparatide (brand name Tymlos) is a parathyroid hormone-related protein (PTHrP) analog drug used to treat osteoporosis. Like the related drug teriparatide, and unlike bisphosphonates, it is an anabolic (i.e., bone growing) agent. In 2017, it was approved to treat postmenopausal osteoporosis in the United States.

-Curatio mulierum postmenopausalis cum osteoporosis in magno periculo fracturae
-Augere massam ossis in hominibus cum osteoporosis primariis vel hypogonadalibus in magno periculo fracturae
-Curatio osteoporosis virorum et mulierum cum therapiis systemicis glucocorticoideis sustentatis in magno periculo fracturae